Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Appili Therapeutics

Appili Therapeutics
2015 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
APLI STOCK SYMBOL
$0.60 SHARE PRICE (As of Friday Closing)
Description

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes three major programs namely ATI-1501, ATI1503, and ATI-1701.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
TSX
Primary Office
  • Suite 21-1344 Summer Street
  • Halifax, Nova Scotia B3H 0A8
  • Canada

+1 (902) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Appili Therapeutics’s full profile, request a free trial.

Appili Therapeutics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.24 - $0.83 $20M $0.60 -$0.12 38.7K 33.6M

Appili Therapeutics Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2019
31-Mar-2019
FY 2018
31-Mar-2018
Enterprise Value 9,230
Revenue 0 0 0
EBITDA (4,046) (3,315) (2,921)
Net Income (4,115) (3,299) (3,097)
Total Assets 2,861 5,119 5,568
Total Debt 761 838 861
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Appili Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Appili Therapeutics‘s full profile, request access.

Request full access to PitchBook

Appili Therapeutics Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Morphotek Formerly VC-backed Exton, PA 000 0000 000000&0 0000
00000 000000000 Formerly VC-backed Boulder, CO 000 00000 000000&0 00000
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000000
000 (0000000000000 Formerly VC-backed San Francisco, CA 000 00000 00000000 00000
00000 00000 000000 Venture Capital-Backed Geneva, Switzerland 000 00000 0000000000 0 00000
To view this company’s complete list of competitors, request access »

Appili Therapeutics Executive Team (5)

Name Title Board
Seat
Contact
Info
Kevin Sullivan Chief Executive Officer & Board Member
Kimberly Stephens Chief Financial Officer & Secretary
Armand Balboni Ph.D Board Member & Executive
Sean McBride Vice President, Business Development
Jamie Doran Vice President of Drug Development

Appili Therapeutics Board Members (11)

Name Representing Role Since Contact
Info
Armand Balboni Ph.D Appili Therapeutics Board Member & Executive 000 0000
Brian Bloom Bloom Burton & Co. Board Member 000 0000
Ian Mortimer Self Board Member 000 0000
John Holyoake Ph.D Bloom Burton & Co. Board Member 000 0000
Juergen Froehlich MD Self Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 11 board members. Get the full list »